Xr Securities LLC Sellas Life Sciences Group, Inc. Call Options Transaction History
Xr Securities LLC
- $0
- Q1 2025
Call Options
2 transactions
Others Institutions Holding SLS
# of Institutions
52Shares Held
14.5MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$11.7 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$4.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.26 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$662,7660.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $31.6M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...